DK237282A - Fremgangsmaade til bestemmelse af antithrambin-bm - Google Patents

Fremgangsmaade til bestemmelse af antithrambin-bm Download PDF

Info

Publication number
DK237282A
DK237282A DK237282A DK237282A DK237282A DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A
Authority
DK
Denmark
Prior art keywords
antithrombin
heparin
determining
cofactor
thrombin
Prior art date
Application number
DK237282A
Other languages
English (en)
Other versions
DK160511C (da
DK160511B (da
Inventor
H Lill
J Schrenk
P Wunderwald
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038163 external-priority patent/DE3038163A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK237282A publication Critical patent/DK237282A/da
Publication of DK160511B publication Critical patent/DK160511B/da
Application granted granted Critical
Publication of DK160511C publication Critical patent/DK160511C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8128—Antithrombin III
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK237282A 1980-10-09 1982-05-26 Fremgangsmaade og reagens til bestemmelse af antithrombin-bm DK160511C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3038163 1980-10-09
DE19803038163 DE3038163A1 (de) 1980-10-09 1980-10-09 Thrombininhibitor, seine herstellung und verwendung
DE3050268 1981-08-04
DE3050268 1981-08-04
PCT/DE1981/000170 WO1982001377A1 (en) 1980-10-09 1981-10-08 Method for determining a bm-antithrombin
DE8100170 1981-10-08

Publications (3)

Publication Number Publication Date
DK237282A true DK237282A (da) 1982-05-26
DK160511B DK160511B (da) 1991-03-18
DK160511C DK160511C (da) 1991-09-30

Family

ID=25788386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK237282A DK160511C (da) 1980-10-09 1982-05-26 Fremgangsmaade og reagens til bestemmelse af antithrombin-bm

Country Status (6)

Country Link
US (1) US4496653A (da)
EP (1) EP0049877B1 (da)
JP (1) JPH0258920B2 (da)
DE (1) DE3163764D1 (da)
DK (1) DK160511C (da)
WO (1) WO1982001377A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3407280A1 (de) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
DE3512909A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung von plasminogenaktivatoren (pa)
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5595735A (en) * 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
JP3094165B2 (ja) * 1990-11-05 2000-10-03 バクスター、ダイアグノスチックス、インコーポレイテッド 抗凝固剤濃度測定方法
DE4203980A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Verfahren zur bestimmung von hirudin und synthetischen thrombininhibitoren
AT397391B (de) * 1992-05-15 1994-03-25 Immuno Ag Verwendung von prothrombinfragmenten
AU4405293A (en) * 1992-06-05 1994-01-04 Barbara M. Alving Test for quantitative thrombin time
US5476771A (en) * 1993-02-22 1995-12-19 The United States Of America As Represented By The Secretary Of The Army Test for quantitative thrombin time
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
EP3198272B1 (en) 2014-09-26 2022-04-06 Abbott Point Of Care, Inc. Cartridge device identification for coagulation assays in fluid samples
CN107110874B (zh) 2014-09-26 2019-06-04 雅培医护站股份有限公司 用于测定流体样品中的凝固的传感器
US10048282B2 (en) 2014-09-26 2018-08-14 Abbott Point Of Care Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
EP3954457A3 (en) 2014-09-26 2022-05-18 Abbott Point Of Care Inc Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
CN106999930B (zh) 2014-09-26 2020-09-08 雅培医护站股份有限公司 用于测定流体样本中的凝结的具有分段射流的盒设备
WO2016049557A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10114031B2 (en) 2014-09-26 2018-10-30 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622286A5 (da) * 1975-06-23 1981-03-31 Pentapharm Ag
SE419871B (sv) * 1975-12-01 1981-08-31 Pharmacia Ab Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod
DE2601372C3 (de) * 1976-01-15 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zur Bestimmung von Antithrombin III
DE2812943C3 (de) * 1978-03-23 1981-05-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
US4216142A (en) * 1978-12-18 1980-08-05 Abbott Laboratories Chromogenic substrates for the proteolytic enzymes
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
EP0018002B1 (de) * 1979-04-24 1983-02-09 Marcel Jozefonvicz Neues Bestimmungsverfahren für Proteasen und Antiproteasen
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity

Also Published As

Publication number Publication date
DK160511C (da) 1991-09-30
JPH0258920B2 (da) 1990-12-11
DK160511B (da) 1991-03-18
EP0049877B1 (de) 1984-05-23
JPS57501510A (da) 1982-08-26
US4496653A (en) 1985-01-29
EP0049877A1 (de) 1982-04-21
WO1982001377A1 (en) 1982-04-29
DE3163764D1 (en) 1984-06-28

Similar Documents

Publication Publication Date Title
Fletcher et al. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products
EP0420332B1 (en) Method for determining the endogenous thrombin potential of plasma and blood, and also a kit for use in said method
Mannello et al. Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases
CA1260369A (en) .alpha. AMYLASE ASSAY
ATE35000T1 (de) Reagenz zur bestimmung der thromboplastinzeit.
Mourão et al. Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm
ES2141106T3 (es) Neutralizacion enzimatica de la heparina.
SE7902555L (sv) Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma
Lewis et al. Automated discrete kinetic method for erythrocyte acetylcholinesterase and plasma cholinesterase.
ATE117311T1 (de) Substrate für hydrolasen, verfahren zu ihrer herstellung und ihre verwendung.
DD156295A6 (de) Verfahren zur bestimmung der biologischen aktivitaet von heparin
IE42546L (en) Method of measuring serum coagulability
McAllister et al. Heparin metabolism: isolation and characterization of uroheparin
Beeler et al. Interaction of factor XIa and antithrombin in the presence and absence of heparin
CN115290581B (zh) 抗Xa测定试剂盒和检测抗Xa活性的方法
EP0049877A1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin-BM
PT87522A (pt) Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern
ES2053457T3 (es) Ensayo de hibridacion en fase solucion para detectar secuencias de polinucleotidos.
ATE52340T1 (de) Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit.
Kindness et al. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas
ATE36557T1 (de) Verfahren zur bestimmung der wirksamkeit von substraten oder enzymen.
BR8003477A (pt) Processo para produzir oxidase de alcool, processo para a determinacao da concentracao de um composto em uma amostra fluida e processo para a oxidacao de um alcool
DE3663684D1 (de) Determination of prokallikrein
US6100050A (en) Factor VIII:Ca chromogenic assay
French et al. A comparison of methods for measuring acetyl cholinesterase activity in blood samples inhibited by carbamates

Legal Events

Date Code Title Description
PBP Patent lapsed